Year |
Citation |
Score |
2018 |
Jung JW, Kim NJ, Yun H, Han YT. Recent Advances in Synthesis of 4-Arylcoumarins. Molecules (Basel, Switzerland). 23. PMID 30241375 DOI: 10.3390/Molecules23102417 |
0.595 |
|
2018 |
Sun SB, Sen S, Kim NJ, Magliery TJ, Schultz PG, Wang F. Retraction of "Mutational Analysis of 48G7 Reveals that Somatic Hypermutation Affects Both Antibody Stability and Binding Affinity". Journal of the American Chemical Society. PMID 29376652 DOI: 10.1021/Jacs.7B08106 |
0.703 |
|
2016 |
Kim T, Kim HI, An JY, Lee J, Lee NR, Heo J, Kim JE, Yu J, Lee YS, Inn KS, Kim NJ. Identification of novel estrogen receptor (ER) agonists that have additional and complementary anti-cancer activities via ER-independent mechanism. Bioorganic & Medicinal Chemistry Letters. PMID 26905830 DOI: 10.1016/j.bmcl.2016.01.089 |
0.606 |
|
2015 |
Lee J, Yu J, Son SH, Heo J, Kim T, An JY, Inn KS, Kim NJ. A versatile approach to flavones via a one-pot Pd(ii)-catalyzed dehydrogenation/oxidative boron-Heck coupling sequence of chromanones. Organic & Biomolecular Chemistry. PMID 26592753 DOI: 10.1039/c5ob01911g |
0.595 |
|
2015 |
Lee JW, Hirota T, Kumar A, Kim NJ, Irle S, Kay SA. Development of Small-Molecule Cryptochrome Stabilizer Derivatives as Modulators of the Circadian Clock. Chemmedchem. 10: 1489-97. PMID 26174033 DOI: 10.1002/Cmdc.201500260 |
0.42 |
|
2015 |
Lim RK, Yu S, Cheng B, Li S, Kim NJ, Cao Y, Chi V, Kim JY, Chatterjee AK, Schultz PG, Tremblay MS, Kazane SA. Targeted Delivery of LXR Agonist Using a Site-Specific Antibody-Drug Conjugate. Bioconjugate Chemistry. 26: 2216-22. PMID 25945727 DOI: 10.1021/Acs.Bioconjchem.5B00203 |
0.697 |
|
2015 |
Lee JW, Hirota T, Kumar A, Kim N, Irle S, Kay SA. Cover Picture: Development of Small-Molecule Cryptochrome Stabilizer Derivatives as Modulators of the Circadian Clock (ChemMedChem 9/2015) Chemmedchem. 10: 1449-1449. DOI: 10.1002/Cmdc.201500345 |
0.387 |
|
2015 |
Kim HJ, Kim SH, Lee YH, Kim DW, Mo K, Kim HJ, Park SH, Jin C, Kim N, Lee YS. Synthesis of 4-(2-Amino)ethoxy-3′,4′-dihydroxychalcones and Their Antioxidant and Cytotoxic Effects on Human Tumor Cells Bulletin of the Korean Chemical Society. 36: 1335-1339. DOI: 10.1002/Bkcs.10253 |
0.327 |
|
2014 |
Kim K, Maharjan S, Lim C, Kim NJ, Agrawal V, Han YT, Lee S, An H, Yun H, Choi HJ, Kwon YG, Suh YG. Glucal-conjugated sterols as novel vascular leakage blocker: structure-activity relationship focusing on the C17-side chain. European Journal of Medicinal Chemistry. 75: 184-94. PMID 24531231 DOI: 10.1016/J.Ejmech.2014.01.027 |
0.583 |
|
2014 |
Chun SK, Jang J, Chung S, Yun H, Kim NJ, Jung JW, Son GH, Suh YG, Kim K. Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock. Acs Chemical Biology. 9: 703-10. PMID 24387302 DOI: 10.1021/Cb400752K |
0.591 |
|
2013 |
Sun SB, Sen S, Kim NJ, Magliery TJ, Schultz PG, Wang F. Mutational analysis of 48G7 reveals that somatic hypermutation affects both antibody stability and binding affinity. Journal of the American Chemical Society. 135: 9980-3. PMID 23795814 DOI: 10.1021/ja402927u |
0.703 |
|
2013 |
Kim NJ, Li FN, Lee JH, Park SG, Kim K, Lim C, Han YT, Yun H, Jung JW, Park HG, Kim HD, Woo BY, Shin SS, Kim SY, Choi JK, et al. Heterocycle-linked phenylbenzyl amides as novel TRPV1 antagonists and their TRPV1 binding modes: constraint-induced enhancement of in vitro and in vivo activities. Chemistry, An Asian Journal. 8: 400-9. PMID 23208797 DOI: 10.1002/Asia.201200730 |
0.624 |
|
2012 |
Chang DJ, An H, Kim KS, Kim HH, Jung J, Lee JM, Kim NJ, Han YT, Yun H, Lee S, Lee G, Lee S, Lee JS, Cha JH, Park JH, et al. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis. Journal of Medicinal Chemistry. 55: 10863-84. PMID 23186287 DOI: 10.1021/Jm301488Q |
0.609 |
|
2012 |
Han YT, Choi GI, Son D, Kim NJ, Yun H, Lee S, Chang DJ, Hong HS, Kim H, Ha HJ, Kim YH, Park HJ, Lee J, Suh YG. Ligand-based design, synthesis, and biological evaluation of 2-aminopyrimidines, a novel series of receptor for advanced glycation end products (RAGE) inhibitors. Journal of Medicinal Chemistry. 55: 9120-35. PMID 22742537 DOI: 10.1021/Jm300172Z |
0.613 |
|
2012 |
Suh YG, Lee YS, Kim SH, Jung JK, Yun H, Jang J, Kim NJ, Jung JW. A stereo-controlled access to functionalized macrolactams via an aza-Claisen rearrangement. Organic & Biomolecular Chemistry. 10: 561-8. PMID 22108849 DOI: 10.1039/C1Ob06733H |
0.602 |
|
2012 |
Sim J, Yun H, Jung J, Lee S, Kim N, Suh Y. Achiral auxiliary-assisted chiral transfer via microwave-accelerated aza-Claisen rearrangement: a short synthesis of (+)-1-hydroxyquinolizidinone Tetrahedron Letters. 53: 4813-4815. DOI: 10.1016/J.Tetlet.2012.06.073 |
0.585 |
|
2011 |
Han YT, Kim NJ, Jung JW, Yun H, Lee S, Suh YG. A versatile synthetic approach to grandisol monoterpene pheromone. Archives of Pharmacal Research. 34: 1437-42. PMID 21975804 DOI: 10.1007/S12272-011-0904-7 |
0.59 |
|
2011 |
Lee S, Paek SM, Yun H, Kim NJ, Suh YG. Enantioselective total synthesis of a natural iridoid. Organic Letters. 13: 3344-7. PMID 21619009 DOI: 10.1021/Ol201089F |
0.599 |
|
2010 |
Kim NJ, Moon H, Park T, Yun H, Jung JW, Chang DJ, Kim DD, Suh YG. Concise and enantioselective total synthesis of 15-deoxy-Δ-(12,14)-prostaglandin J(2). The Journal of Organic Chemistry. 75: 7458-60. PMID 20929274 DOI: 10.1021/Jo101523K |
0.586 |
|
2009 |
Yun H, Paek SM, Jung JW, Kim NJ, Kim SH, Suh YG. First total syntheses of (-)-macrosphelides J and K and elucidation of their absolute configuration. Chemical Communications (Cambridge, England). 2463-5. PMID 19532857 DOI: 10.1039/B817693K |
0.543 |
|
2009 |
Paek SM, Yun H, Kim NJ, Jung JW, Chang DJ, Lee S, Yoo J, Park HJ, Suh YG. Concise syntheses of (+)-macrosphelides A and B: studies on the macro-ring closure strategy. The Journal of Organic Chemistry. 74: 554-61. PMID 19086801 DOI: 10.1021/Jo8016692 |
0.596 |
|
Show low-probability matches. |